Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.9.70 CHF
Change Today +0.58 / 6.36%
Volume 2.1K
SHLTN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
OTC US
OTC US
As of 5:44 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

shl telemedicine ltd-reg (SHLTN) Snapshot

Open
SFr.9.70
Previous Close
SFr.9.12
Day High
SFr.9.70
Day Low
SFr.9.70
52 Week High
04/20/15 - SFr.10.20
52 Week Low
08/4/14 - SFr.7.05
Market Cap
105.5M
Average Volume 10 Days
71.4K
EPS TTM
SFr.0.08
Shares Outstanding
10.9M
EX-Date
09/20/11
P/E TM
131.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for SHL TELEMEDICINE LTD-REG (SHLTN)

Related News

No related news articles were found.

shl telemedicine ltd-reg (SHLTN) Related Businessweek News

No Related Businessweek News Found

shl telemedicine ltd-reg (SHLTN) Details

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine systems in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12-lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter that transmits a patient's complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions; Cardio'B, a portable device, which transmits a 12-lead ECG; and CardioBeeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote, electronic, handheld device to test how well the lungs are working; and TelePulse Oximeter, an electronic, handheld diagnostic device to measure the saturation level of oxygen in blood and pulse rate. In addition, it offers medical call center services with a focus on cardiovascular and related diseases to end users, as well as to the healthcare community. The company offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.

448 Employees
Last Reported Date: 03/25/15
Founded in 1987

shl telemedicine ltd-reg (SHLTN) Top Compensated Officers

Co-Chief Executive Officer
Total Annual Compensation: $555.8K
Co-Chief Executive Officer
Total Annual Compensation: $550.3K
Compensation as of Fiscal Year 2014.

shl telemedicine ltd-reg (SHLTN) Key Developments

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. announced that the board of directors has unanimously resolved to appoint Mr. Eli Alroy to serve as a member of the board. In addition, Mr. Eli Ayalon has announced his resignation from the board of directors effective immediately. Mr. Eli Alroy is the managing director of A.Y.R.A.D. Investment Ltd. From 1994 to 2012, Mr. Alroy was the chairman of the supervisory board of Globe Trade Centre S.A.

SHL Telemedicine Evaluates Sstrategic Options

SHL Telemedicine Ltd. (SWX:SHLTN) is evaluating strategic options, including a potential merger or sale. Related discussions with several entities are currently on-going. SHL Telemedicine retained a leading investment bank to accompany it in the process. No agreement has yet been reached and no assurance can be given that these discussions will lead to a definitive agreement. SHL Telemedicine will inform the public of any material developments in this respect.

SHL Telemedicine Reports Consolidated Unaudited Earnings Results for the Fourth Quarter and Audited Earnings Results for the Full Year Ended December 31, 2014

SHL Telemedicine reported consolidated unaudited earnings results for the fourth quarter and audited earnings results for the full year ended December 31, 2014. For the quarter, the company reported revenues of USD 9,048,000 against USD 7,733,000 a year ago. EBIT was USD 0.6 million against USD 3.1 million a year ago. EBITDA was USD 2.0 million against USD 4.3 million a year ago. Net income was USD 0.5 million or USD 0.05 per basic and diluted share against USD 3.7 million or USD 0.36 per basic and diluted share a year ago. Operating income was USD 549,000 against USD 3,150,000 a year ago. Income before taxes on income was USD 597,000 against USD 2,702,000 a year ago. Cash Flow from operations USD 0.1 million compared to a negative operating cash flow of USD 0.1 million a year ago. For the full year, the company reported revenues of USD 39,976,000 against USD 29,674,000 a year ago. EBIT was USD 1.3 million against USD 3.1 million a year ago. EBITDA was USD 7.4 million against USD 8.1 million a year ago. Net income was USD 0.8 million or USD 0.08 per basic and diluted share against USD 2.2 million or USD 0.22 per basic and diluted share a year ago. Operating income was USD 549,000 against USD 3,150,000 a year ago. Income before taxes on income was USD 597,000 against USD 2,702,000 a year ago. Cash used in operations amounted to USD 3.1 million compared to USD 2.6 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHLTN:SW SFr.9.70 CHF +0.58

SHLTN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTelemetry Inc $8.15 USD +0.14
Health Revenue Assurance Holdings Inc $0.0006 USD -0.0001
LifeWatch AG SFr.15.00 CHF -0.10
View Industry Companies
 

Industry Analysis

SHLTN

Industry Average

Valuation SHLTN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHL TELEMEDICINE LTD-REG, please visit www.shl-telemedicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.